Sovelbek® is indicated for the treatment of chronic hepatitis C virus (HCV) infection in patients 6 years of age and older weighing at least 17 kg.
DCI | Sofosbuvir/Velpatasvir |
---|---|
Dosage | 400/100 mg |
Trade name | Sovelbek® |
Name of the originator | Epclusa |
Presentation | 28 tablets |
Specialty | Hépatologie-AAD |